It's never been associated with injectible PPS. There are no examples whatsoever, and that's probably due to the treatment doses used in subcutaneous injection being miniscule compared to the cumulative long-term use of oral administration e.g. Elmiron for IC.
Despite that, PAR have previously mentioned that they will be monitoring for this in their Phase III trials.
- Forums
- ASX - By Stock
- PAR
- Worst Case Consideration
Worst Case Consideration, page-14
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
(20min delay)
|
|||||
Last
26.0¢ |
Change
0.055(26.8%) |
Mkt cap ! $85.80M |
Open | High | Low | Value | Volume |
21.0¢ | 26.0¢ | 21.0¢ | $751.4K | 3.154M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 57054 | 25.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
26.0¢ | 49570 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 57054 | 0.255 |
6 | 105829 | 0.250 |
6 | 61886 | 0.245 |
7 | 75304 | 0.240 |
6 | 68162 | 0.235 |
Price($) | Vol. | No. |
---|---|---|
0.260 | 49570 | 6 |
0.265 | 67464 | 8 |
0.270 | 102453 | 8 |
0.275 | 59816 | 5 |
0.280 | 24681 | 2 |
Last trade - 15.06pm 17/10/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non Executive Director
Simon Kidston
Non Executive Director
SPONSORED BY The Market Online